Modern Water acquires division of Strategic Diagnostics

Water technologies company Modern Water has acquired the water quality division of Strategic Diagnostics, including its Microtox toxicity testing technology.

Modern Water expects to benefit from synergies, as both Cymtox and Microtox use the same platform bioluminescent technology and the combined expertise in this field provides a strong base for future product development.

There are also geographical benefits to the acquisition, as Microtox sales are expected to capitalise on the distribution channels Cogent and Cymtox have established in China and Asia.

Moreover, sales of Modern Water’s existing products should be enhanced by the strength of the sales team and distribution partners in the US and Canada.